Cytometry Part B-Clinical Cytometry

Papers
(The median citation count of Cytometry Part B-Clinical Cytometry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue highlights—January 202543
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease39
27
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10 23
21
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells20
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring16
15
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel15
Issue highlights—September 202315
Standardization of flow cytometric detection of antigen expression15
Issue Information15
14
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients14
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia14
Issue Information14
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi13
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.12
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma12
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa11
Issue Highlights—January 202210
Issue Information10
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis10
Issue Information9
Issue Information9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
Issue Information9
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T 8
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays7
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia7
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry7
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 7
Anti‐CD38 VHH antibody (JK36) reliably detects CD38 yet uncovers CD38 downregulation in a subset of daratumumab‐treated multiple myeloma patients7
6
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
6
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine6
6
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in t5
5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Issue Information5
Editorial on IVD cellular assay validation5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
Issue Highlights—July 20224
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia4
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis4
4
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease4
Issue Highlights—November 20254
Issue Information4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
Issue highlights—November 20244
Issue Highlights—July 20254
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases4
Signal without noise: Practical antibody titration for platelet flow cytometry4
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis4
Issue highlights—September 20243
Issue Information3
Issue Highlights—March 20223
3
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia3
Comment on “An unusual pattern observed upon the addition of CD79b to a flow‐Cytometry B‐cell Lymphoma panel” ( Cytometry B Cl3
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition3
Flow cytometry in the diagnosis of myelodysplastic syndromes3
Issue highlights—July 20243
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions3
Challenges and approaches in the diagnosis and differential diagnosis of atypical CLL : A response to ‘Defining atypical CLL3
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience3
Issue highlights—May 20233
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study3
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent3
3
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder3
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern3
Issue Information3
Issue Information2
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection2
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp2
Issue Information2
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia2
Artificial Intelligence Issue Highlights2
Authors' Response to Letter from Khanolkar and Ahmed concerning our article “An unusual pattern observed upon the addition of CD79b to a flow cytomet2
2
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes2
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow2
2
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS2
CD200 expression in CD4 + T‐cells: Diagnostic implications across T‐cell lymphomas2
Issue Highlights—September 20222
Noel Warner Ph.D.2
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country2
Recommendations for using artificial intelligence in clinical flow cytometry2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow2
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients2
Issue highlights—July 20232
Establishment of a flow cytometric platelet crossmatching assay and its clinical application in platelet refractoriness2
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome2
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry2
The role of CD20+ T cells: Insights in human peripheral blood2
AI in flow cytometry: Current applications and future directions2
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy2
Issue Highlights—May 20221
Issue highlights—November 20221
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands1
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor 1
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes1
Issue Information1
Issue Information1
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di1
Bridging the implementation gap in AI ‐assisted flow cytometry1
1
Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot‐plot based analysis for flow cytometry1
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders1
1
1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies1
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry1
Issue Information1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation1
Automation in flow cytometry: Guidelines and review of systems1
1
1
Issue Information1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia1
0.23894619941711